Illumina, others should mediate before gene-testing patents trial, UK judge says
Illumina, a maker of gene-sequencing equipment, and other parties involved in a patent dispute over prenatal testing have been told by a London court to mediate before the trial starts next...To view the full article, register now.
Already a subscriber? Click here to view full article